期刊文献+

DWI在早期评估骨肉瘤新辅助化疗疗效中的应用价值 被引量:12

Application value of diffusion weighted imaging in early evaluation of neoadjuvant chemotherapy for Osteosarcoma
下载PDF
导出
摘要 目的:探讨磁共振扩散加权成像(DWI)在早期评估骨肉瘤化疗疗效中的应用价值。方法:搜集行新辅助化疗的骨肉瘤患者11例,患者分别于新辅助化疗开始前、第1个化疗周期结束后、所有4个化疗周期结束后行常规MRI及DWI检查,检测骨肉瘤内水分子扩散及血液灌注变化情况,观察新辅助化疗过程中骨肉瘤形态、大小结构等方面的变化情况。结果:9例患者化疗后肿瘤体积增大,2例患者化疗后肿瘤体积变小或不变,化疗前与化疗早期的ADC值差异有统计学意义(P<0.05)。将化疗前、化疗第1周期结束后的ADC值及两次ADC变化量与肿瘤坏死率进行相关性分析,其中ADC值变化量与肿瘤坏死率存在相关性(r=0.397,P=0.020)。结论:化疗第1周期结束时ADC值变化量可以反映肿瘤坏死率情况,为预测新辅助化疗效果、评估治疗方案提供新的影像学思路。 Objective:The purpose of this study was to evaluate the value of diffusion weighted imaging(DWI)in predicting the efficacy of neoadjuvant chemotherapy for osteosarcoma at early stage.Methods:Eleven patients with osteosarcoma treated with neoadjuvant chemotherapy in the First Affiliated Hospital of Guangxi Medical University from 2017 to 2019 were collected.MRI scan(conventional and DWI)was performed before neoadjuvant chemotherapy,after the end of the first stage,after all four stages of chemotherapy.The diffusion of water molecules and the changes of blood perfusion in osteosarcoma were detected,and the morphology,size and structure of osteosarcoma were observed during neoadjuvant chemotherapy.Results:The tumor volume increased in 9 patients and decreased or remained unchanged in 2 patients after chemotherapy.The difference between the ADC values before and after the first stage of chemotherapy were statistically significant(P<0.05).Correlation analysis was made between the ADC value before chemotherapy,after the first stage of chemotherapy and the change of ADC value with tumor necrosis rate.There was a correlation between the change of ADC value and tumor necrosis rate(r=0.397,P=0.020<0.05).Conclusion:The changes of ADC value at the end of the first stage of neoadjuvant chemotherapy for osteosarcoma can reflect the situation of tumor necrosis rate,which can be used as a new approach to predict the efficacy of neoadjuvant chemotherapy.
作者 任浩 丘金凤 黄丽轩 李文美 马劼 宋英儒 REN Hao;QIU Jin-feng;HUANG Li-xuan(Department of radiology,the Langdong Affiliated Hospital of Guangxi Medical University,Nanning 530000,China)
出处 《放射学实践》 CSCD 北大核心 2021年第1期42-46,共5页 Radiologic Practice
关键词 骨肉瘤 新辅助化疗 疗效评估 磁共振成像 扩散加权成像 表观扩散系数 Osteosarcoma Neoadjuvant chemotherapy Efficacy evaluation Magnetic resonance imaging Diffusion weighted imaging Apparent diffusion coefficient
  • 相关文献

参考文献8

二级参考文献65

  • 1孟悛非,马玲,陈应明,江波.EPI-DWI-ADC图对确定恶性骨肿瘤髓内浸润范围的价值[J].中国CT和MRI杂志,2003,1(1):46-51. 被引量:5
  • 2马玲,孟悛非,陈应明,江波.表观扩散系数值在原发性恶性骨肿瘤诊断中的价值[J].中华放射学杂志,2004,38(11):1129-1134. 被引量:19
  • 3马林.骨肉瘤CT表现及其与预后的相关性研究[J].中国临床医学影像杂志,2005,16(12):719-720. 被引量:10
  • 4孙军辉,崔建岭,李建平.移植骨肉瘤磁共振弥散加权成像特点及价值[J].肿瘤防治研究,2006,33(12):892-894. 被引量:3
  • 5Bielack S,Carrle D,Casali PG.Osteosarcoma:ESMO clinical rec-ommendations for diagnosis,treatment and follow-up[J].Ann On-col,2009,20(Suppl 4):S137-S139.
  • 6Provisor AJ,Ettinger LJ,Nachman JB,et al.Treatment of non-metastatic osteosarcoma of the extremity with preoperative andpostoperative chemotherapy:a report from the Children′s CancerGroup[J].J Clin Oncol,1997,15(1):76-84.
  • 7Bramer JA,van Linge JH,Grimer RJ,et al.Prognostic factors inlocalized extremity osteosarcoma:a systematic review[J].Eur JSurg Oncol,2009,35(10):1030-1036.
  • 8Rosen G,Caparros B,Huvos AG,et al.Preoperative chemothera-py for osteogenic sarcoma:selection of postoperative adjuvantchemotherapy based on the response of the primary tumor to pre-operative chemotherapy[J].Cancer,1982,49(6):1221-1230.
  • 9Hayashida Y,Yakushiji T,Awai K,et al.Monitoring therapeuticresponses of primary bone tumors by diffusion-weighted image:in-itial results[J].Eur Radiol,2006,16(12):2637-2643.
  • 10Uhl M,Saueressig U,Koehler G,et al.Evaluation of tumour nec-rosis during chemotherapy with diffusion-weighted MR imaging:preliminary results in osteosarcomas[J].Pediatr Radiol,2006,36(12):1306-1311.

共引文献88

同被引文献111

引证文献12

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部